Amarin Corp Plc (AMRN): Here’s some follow up information to: $...

Reply Private New

Replies (2) Next 10 Prev Next

Send PM Follow Ignore

Followers	58
Posts	3948
Boards Moderated	0
Alias Born	04/23/2013

CaptBeer

Re: None

Monday, 11/14/2022 11:51:04 AM

Monday, November 14, 2022 11:51:04 AM

Here’s some follow up information to:
$AMRN Sunday School Class for Sunday, November 13, 2022
Topic: Formulary Foolery

Is it time for an Authorized Generic?

In my original post, read it here:
https://drive.google.com/file/d/1rXkr0ILMonA1iPSH5No0UDToVbNWeM59/view?usp=sharing

I provided some talking points that one could use when challenging formulary decisions by PBM’s. These include some scientific, some legal and even some ethical. In this follow up I continue in that vein with the added emphasis that the top priorities for PBM’s are not to select the products with the most clinical benefits, but to prioritize products which are “good enough” and Cheaper than the branded products. Thus, in addition to the proven scientific benefits of branded VASCEPA® one must also consider the cost effectiveness of branded vs. generics. That’s a judgement call.

Read this follow up:
https://drive.google.com/file/d/1tRR1uQsaRpAmXd-Un8qBk8VY-RRgnanC/view?usp=sharing